AbCellera Biologics Inc. Common Shares - Grafik, Fiyat ve Haberler (NASDAQ:ABCL)

Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler

Çeyreklik Yıllık

Market Capitalization 1.89 B
Employee 562
Founded 2012
CEO Carl Hansen
Website www.abcellera.com
Headquarter British Columbia, Canada
FIGI BBG00LLW2MF2
Industry Biyoteknoloji

Toplam gelir

Net kar

Temel hisse başına kazanç (Temel EPS)

Toplam borç

Serbest nakit akışı

Nakit ve eşdeğerleri

Fiyat/kazanç oranı

-6.98

Fiyat/satışlar oranı

13.6

AbCellera Biologics Inc. - Common Shares

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

ABCL

Financials

AbCellera Biologics Inc. - Common Shares

Haberler

After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright

Truist, klinik veri vaadi üzerine AbCellera hisse hedefini yükseltti

Wall Street Analysts Believe ABCELLERA BIOLG (ABCL) Could Rally 97.28%: Here's is How to Trade

Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year?

AbCellera Biologics Inc. (ABCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Cantor, menopoz ilacı verileriyle AbCellera hisse hedefini yükseltti

Stifel, klinik veri gücüyle AbCellera hisse hedefini yükseltti

AbCellera Biologics Inc. (ABCL) Q1 2026 Earnings Call Transcript

AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates

AbCellera kazanç raporu ve ilk klinik veri açıklaması yaklaşıyor

Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates

Arcus Biosciences, Inc. (RCUS) Reports Q1 Loss, Beats Revenue Estimates